Les vaccins coquelucheux acellulaires : l'expérience suédoiseGRANSTRÖM, M.Médecine & enfance. 2001, Vol 21, Num 8, pp 5-6, issn 0291-0233, SUPConference Paper

Le vaccin coquelucheux acellulaire à trois composants induit une immunité aussi longue que le vaccin à germes entiersGUISO, N.Médecine & enfance. 2007, Vol 27, Num 7, pp 370-371, issn 0291-0233, 2 p., CAH2Article

Different Effects of Whole-Cell and Acellular Vaccines on Bordetella TransmissionSMALLRIDGE, William E; ROLIN, Olivier Y; JACOBS, Nathan T et al.The Journal of infectious diseases. 2014, Vol 209, Num 12, pp 1981-1988, issn 0022-1899, 8 p.Article

Quel vaccin coquelucheux et à quel âge ?GAUDELUS, Joël; GUISO, Nicole; COHEN, Robert et al.MTP. Médecine thérapeutique pédiatrie. 2006, Vol 9, Num 3, pp 160-169, issn 1286-5494, 10 p.Article

Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in miceFEUNOU, Pascal F; KAMMOUN, Hana; DEBRIE, Anne-Sophie et al.Vaccine. 2014, Vol 32, Num 34, pp 4281-4288, issn 0264-410X, 8 p.Article

Cost―benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)YAO DING; YEH, Sylvia H; MINK, Chris Anna M et al.Vaccine. 2013, Vol 31, Num 22, pp 2558-2564, issn 0264-410X, 7 p.Article

Economic impact of the introduction of an acellular pertussis vaccine in Canada: A 6-year analysisISKEDJIAN, Michael; DE SERRES, Gaston; EINARSON, Thomas R et al.Vaccine. 2010, Vol 28, Num 3, pp 714-723, issn 0264-410X, 10 p.Article

An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccinesYUEN, Chun-Ting; HORIUCHI, Yoshinobu; ASOKANATHAN, Catpagavalli et al.Vaccine. 2010, Vol 28, Num 21, pp 3714-3721, issn 0264-410X, 8 p.Article

Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccineSEKARAN, Nishant K; EDWARDS, Kathryn M.The Pediatric infectious disease journal. 2006, Vol 25, Num 4, pp 374-375, issn 0891-3668, 2 p.Article

New acellular pertussis-containing paediatric combined vaccinesPINES, E; BARRAND, M; FABRE, P et al.Vaccine. 1999, Vol 17, Num 13-14, pp 1650-1656, issn 0264-410XConference Paper

A cellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in childrenKANRA, G; CEYHAN, M; VANDEVOORDE, D et al.European journal of pediatrics. 1993, Vol 152, Num 6, pp 478-483, issn 0340-6199Article

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumanniiMCCONNELL, Michael J; RUMBO, Carlos; BOU, German et al.Vaccine. 2011, Vol 29, Num 34, pp 5705-5710, issn 0264-410X, 6 p.Article

Modified intra-cerebral challenge assay for acellular pertussis vaccines: Comparisons among whole cell and acellular vaccinesGAINES-DAS, R; HORIUCHI, Y; ZHANG, S. M et al.Vaccine. 2009, Vol 27, Num 49, pp 6824-6832, issn 0264-410X, 9 p.Article

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigensSCHEIFELE, David W; HALPERIN, Scott A; FERGUSON, Alexander C et al.Vaccine. 2001, Vol 19, Num 32, pp 4720-4726, issn 0264-410XArticle

Acellular pertussis vaccine composed on genetically inactivated pertussis toxin : safety and immunogenicity in 12- to 24- and 2- to 4-month-old childrenPODDA, A; CARAPELLA DE LUCA, E; TITONE, L et al.The Journal of pediatrics. 1992, Vol 120, Num 5, pp 680-685, issn 0022-3476Article

Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccinationPRELOG, M; ALMANZAR, G; RIEBER, N et al.Vaccine. 2013, Vol 31, Num 2, pp 387-393, issn 0264-410X, 7 p.Article

Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid componentJACKSON, Lisa A; FALLS, Sherry; ONCHEE YU et al.The Journal of infectious diseases. 2001, Vol 183, Num 11, pp 1698-1700, issn 0022-1899Article

Local reactions after the fourth-dose of acellular pertussis vaccine in South AustraliaGOLD, Michael S; NOONAN, Sara; OSBOURN, Maggi et al.Medical journal of Australia. 2003, Vol 179, Num 4, pp 191-194, issn 0025-729X, 4 p.Article

Primovaccination : du vaccin coquelucheux entier au vaccin coquelucheux acellulaire à trois composants = First immunization, from whole pertussis vaccine to three components acellular oneGAUDELUS, J.Médecine & enfance. 2001, Vol 21, Num MAI, pp 13-14, issn 0291-0233, SUPArticle

Antibody and Cell-mediated Immunity to Pertussis 4 Years After Monovalent Acellular Pertussis Vaccine at BirthWOOD, Nicholas; MARSHALL, Helen; WHITE, Olivia J et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 5, pp 511-517, issn 0891-3668, 7 p.Article

Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccineHEGERLE, N; DORE, G; GUISO, N et al.Vaccine. 2014, Vol 32, Num 49, pp 6597-6600, issn 0264-410X, 4 p.Article

Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010MORO, Pedro L; XIN YUE; LEWIS, Paige et al.Vaccine. 2011, Vol 29, Num 50, pp 9404-9408, issn 0264-410X, 5 p.Article

Effectiveness of Adolescent and Adult Tetanus, Reduced-Dose Diphtheria, and Acellular Pertussis Vaccine against PertussisWEI, Stanley C; TATTI, Kathleen; TONDELLA, Maria Lucia et al.Clinical infectious diseases. 2010, Vol 51, Num 3, pp 315-321, issn 1058-4838, 7 p.Article

Booster Vaccination After Neonatal Priming with Acellular Pertussis VaccineKNUF, Markus; SCHMITT, Heinz-Josef; JACQUET, Jeanne-Marie et al.The Journal of pediatrics. 2010, Vol 156, Num 4, pp 675-678, issn 0022-3476, 4 p.Article

Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancyDIRIX, V; VERSCHEURE, V; GOETGHEBUER, T et al.Vaccine. 2009, Vol 27, Num 43, pp 6042-6047, issn 0264-410X, 6 p.Article